SCHEMBL7417828

SCHEMBL7417828

O=C(CCNS(=O)(=O)c1ccc(Br)cc1)NO

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEP1B Q16820 3/20 0.72
MMP2 P08253 5/20 0.70
MMP9 P14780 5/20 0.70
MMP13 P45452 4/20 0.65
MMP14 P50281 2/20 0.65
ADAMTS4 O75173 1/20 0.65
ADAMTS5 Q9UNA0 1/20 0.65
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
MMP1 P03956 3/20 0.58
ADAM17 P78536 2/20 0.58
RAB9A P51151 1/20 0.57
ALDH1A1 P00352 1/20 0.56
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
MMP8 P22894 1/20 0.55
KDM4E B2RXH2 1/20 0.54
SIGMAR1 Q99720 1/20 0.54
MMP3 P08254 1/20 0.54
MMP7 P09237 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18498698 0.87 MEN1 (0.57) MEP1BMMP2MMP9MMP13MMP14
SCHEMBL7413923 0.83 MMP2 (0.72) MEP1BMMP2MMP9MMP13MMP14
SCHEMBL9577239 0.82 SIGMAR1 (0.68) MMP2MMP9MMP13MEN1KMT2A
SCHEMBL7417568 0.81 MMP13 (0.71) MEP1BMMP2MMP9MMP13MMP14
SCHEMBL18498935 0.81 IDO1 (0.56) MMP2MMP9MMP13MEN1KMT2A
SCHEMBL13401889 0.80 KMT2A (0.67) MMP2MMP9MEN1KMT2ARAB9A
SCHEMBL19334435 0.79 RAB9A (0.73) MMP2MMP9MMP13MEN1KMT2A
SCHEMBL1348420 0.79 ALDH1A1 (0.64) MMP2MMP9MMP13MEN1KMT2A
SCHEMBL18498803 0.79 ALDH1A1 (0.58) MMP2MMP9MMP13MEN1KMT2A
SCHEMBL13401888 0.78 POLB (0.70) MEN1KMT2ARAB9AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed